| Study | Diagnosis |
Patient no. intervention/control | Treatment |
Treatment duration (days) |
Followup (months) | Intervention | Control |
| Qi et al [18], 1996 | SA | 26/20 | Shexiangbaoxin tablets + WM | WM | 14 | NR | Liu and Gong [19], 2003 | SA | 38/37 | Shengmai capsules + WM | WM | NR | 6 | Shen et al. [20], 2003 | SA | 45/42 |
Fufangdanshen dripping pills + | WM | NR | 36 | Yu et al. [21], 2006 | SA | 32/33 | Xuezhikang capsules + WM | WM | 180 | 6 | Hou [22], 2007 | SA | 63/60 | Danhong In + WM | WM | 14 | 1 | Yao et al. [23], 2007 | SA | 60/60 | Weiaoxin + WM + placebo | WM + placebo | 30 | 12 | Gao et al. [24], 2008 | SA | 40/36 | Yiqihuoxuefang + WM without antiplatelet drug | WM without antiplatelet drug | 30 | 1 | Li [25], 2008 | SA | 50/50 | Dengzhanshengmai capsules + WM | WM | 360 | 12 | Ye [26], 2009 | SA | 55/55 | Xinyuan capsules + Simvastahn | Simvastahn | 365 | 12 | Long et al. [27], 2000 | UA | 23/23 | Tongxinluo capsules + WM | WM | NR | NR | Wu and Cui [28], 2001 | UA | 20/20 | Shuxuetong In + WM | WM | 10 | NR | Xiao et al. [29], 2001 | UA | 40/38 | Xuezhikang capsules + WM | WM | 90 | 3 | Deng [30], 2002 | UA | 35/22 | Ziniguanxintong decoction + WM | WM | 58 | 2 | Yang [31], 2002 | UA | 75/75 | Ruxinan capsules + WM | WM | 21 | 3 | Zhao [32], 2002 | UA | 23/23 | Xuesaitong pills + WM | WM | NR | NR | Gao et al [33], 2003 | UA | 33/33 | Xintong oral liquid + WM | WM | 90 | 3 | Hong et al [34], 2003 | UA | 60/60 | Fufangdanshen dripping pills + WM | WM | 28 | 6 |
Nian [35], 2003 | UA | 15/15 | Tongxinluo capsules + WM | WM | 28 | 1 | Zhang and Hong [36], 2003 | UA | 50/50 | Fufangdanshen dripping pills + WM | WM | 28 | 6 | Chen [37], 2004 | UA | 30/27 | Shexiangbaoxin pills + WM | WM | 28 | 48 | Chen et al. [38], 2005 | UA | 27/23 | Ciwujia In + WM | WM | 14 | 3 | Peng [39], 2005 | UA | 46/46 | Shuxuening In + WM + aspirin + dinitrosorbide | WM + aspirin + dinitrosorbide | NR | NR | Liu and Wang [40], 2006 | UA | 32/32 | Tongxinluo capsules + WM | WM | 56 | 2 | Yuan et al. [41], 2006 | UA | 46/46 | Shuxuening In + WM | WM | 14 | 6 |
Ning et al. [42], 2007 | UA | 56/56 | Tanshinone II A sulfoacid In + WM | WM | 14 | 6 | Ma et al. [43], 2007 | UA | 30/29 | Tanshinone II A sulfoacid In + WM + dinitrosorbide | WM + dinitrosorbide | 14 | 1 | Xiao [44], 2007 | UA | 30/28 | Chaihuxianxiong decoction + WM | WM | 30 | 6 | Yang et al. [45], 2007 | UA | 31/31 | Buxuzhuyuheji + WM | WM | 14 | 6 | Cai and Wei [46], 2008 | UA | 56/56 | Danshendongganfen + WM | WM | 14 | 6 | Cai [47], 2008 | UA | 56/54 | Gegensu capsules + WM | WM | 14 | 2 | Chen and Fan [48], 2008 | UA | 30/30 | Xintongfang + WM + dinitrosorbide | WM + dinitrosorbide | 28 | 1 | Liu [49], 2008 | UA | 31/31 | Gegensu In + WM | WM | 14 | 3 | Zhang and Chen [50], 2008 | UA | 45/45 | Tongxinluo capsules + WM | WM | NR | 1.5 | Cai and Wang [51], 2009 | UA | 58/50 | Tongxinluo capsules + WM + dinitrosorbide | WM + dinitrosorbide | 28 | 1 | Chen and Ye [52], 2009 | UA | 50/50 | Dengzhanshengmai capsules+ WM | WM | 180 | 6 | Su et al. [53], 2009 | UA | 60/58 | Danhong In + WM | WM | 14 | NR | Wang [54], 2009 | UA | 44/42 | Gegensu In + WM | WM | 14 | 2 | Wang et al. [55], 2009 | UA | 37/34 | Shuxuetong In + WM | WM | 7 | NR | Yu and Chen [56], 2009 | UA | 68/30 | Tongxinluo capsules + WM | WM | NR | 3 | He et al. [57], 2010 | UA | 54/54 | Yiqiyangyinfang + WM | WM | 28 | 8 | Wu and Li [58], 2005 | SA or UA | 93/123 | Tongxinluo capsules + WM | WM | 14 | 0.5 | Li et al. [59], 2008 | SA or UA | 136/135 | Quyuningxin WM pills + WM | WM | 14 | 0.5 | Dong [60], 2008 | SA or UA | 80/79 | Shexiangbaoxin pills + WM + dinitrosorbide | WM + dinitrosorbide | 90 | 3 | H. Shi and Q. Shi [61], 2009 | SA or UA | 63/61 | Fufangdanshen dripping pills + WM | WM | NR | 12 | Shi and Jiang [62], 2009 | SA or UA | 30/30 | Tongxinluo capsules + WM atorvastatin | WM atorvastatin | 180 | 6 | Lin and Wu [63], 2010 | SA or UA | 39/39 | Fufangdanshen dripping pills + WM | WM | 28 | 6 |
|
|